{"id":"https://openalex.org/W4362432330","doi":"https://doi.org/10.1158/1078-0432.22481064","title":"Supplementary Data from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma","display_name":"Supplementary Data from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362432330","doi":"https://doi.org/10.1158/1078-0432.22481064"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22481064","doi":"https://doi.org/10.1158/1078-0432.22481064","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481064","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.22481064","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045079164","display_name":"Joseph M. Tuscano","orcid":"https://orcid.org/0000-0002-0522-1406","observed_orcids":["https://orcid.org/0000-0002-0522-1406"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph M. Tuscano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054146743","display_name":"Christina Poh","orcid":"https://orcid.org/0000-0003-3120-712X","observed_orcids":["https://orcid.org/0000-0003-3120-712X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Poh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066543172","display_name":"Paul R. Kaesberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Kaesberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084956764","display_name":"Guillaume Luxardi","orcid":"https://orcid.org/0000-0003-3338-0583","observed_orcids":["https://orcid.org/0000-0003-3338-0583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guilluame Luxardi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3338-0583","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032164345","display_name":"Alexander A. Merleev","orcid":"https://orcid.org/0000-0002-5735-7233","observed_orcids":["https://orcid.org/0000-0002-5735-7233","https://orcid.org/0000-0002-5031-4775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Merleev","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5735-7233","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076958813","display_name":"Alina I. Marusina","orcid":"https://orcid.org/0000-0002-2352-315X","observed_orcids":["https://orcid.org/0000-0002-2352-315X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alina Marusina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060558335","display_name":"Ann M. Brunson","orcid":"https://orcid.org/0000-0001-5308-9457","observed_orcids":["https://orcid.org/0000-0001-5308-9457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann Brunson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Aaron Rosenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron Rosenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068133376","display_name":"Brian Andrew Jonas","orcid":"https://orcid.org/0000-0002-4921-5809","observed_orcids":["https://orcid.org/0000-0002-4921-5809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Jonas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4921-5809","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030729248","display_name":"Emanual Michael Maverakis","orcid":"https://orcid.org/0000-0002-6294-6294","observed_orcids":["https://orcid.org/0000-0002-6294-6294"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emanual Maverakis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6294-6294","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/indolent-lymphoma","display_name":"indolent lymphoma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/previously-untreated-lymphoma","display_name":"previously untreated lymphoma","score":0.7649999856948853},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.781000018119812},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.9505054950714111},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7007426023483276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6374846696853638},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5416801571846008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4716431498527527},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45803192257881165},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45089980959892273},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.36541223526000977},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25352174043655396},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.14202409982681274},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.11335566639900208},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22481064","doi":"https://doi.org/10.1158/1078-0432.22481064","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481064","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22481064","doi":"https://doi.org/10.1158/1078-0432.22481064","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22481064","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8999999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2950334334","https://openalex.org/W2953768725","https://openalex.org/W3164387393","https://openalex.org/W4361947385","https://openalex.org/W2585215038","https://openalex.org/W4310163273","https://openalex.org/W4248032205","https://openalex.org/W2577203079","https://openalex.org/W2954631143","https://openalex.org/W4296528839"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Long-term":[3],"Follow-up":[4],"and":[5,15,23],"Correlative":[6],"Analysis":[7],"of":[8,13],"Two":[9],"Phase":[10],"II":[11],"Trials":[12],"Rituximab":[14],"Lenalidomide":[16,20],"Followed":[17],"by":[18],"Continuous":[19],"in":[21],"Untreated":[22],"Relapsed/Refractory":[24],"Indolent":[25],"Lymphoma":[26]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}